Crossref journal-article
Wiley
Journal of Transplantation (311)
Abstract

Although current therapies for pretransplant desensitization and treatment of antibody-mediated rejection (AMR) have had some success, they do not specifically deplete plasma cells that produce antihuman leukocyte antigen (HLA) antibodies. Bortezomib, a proteasome inhibitor approved for the treatment of multiple myeloma (a plasma cell neoplasm), induces plasma cell apoptosis. In this paper we review the current body of literature regarding the use of this biological agent in the field of transplantation. Although limited experience with bortezomib may seem to show promise in the realm of transplant recipients desensitization and treatment of AMR, there is also experience that may suggest otherwise. Bortezomib's role in desensitization protocols and treatment of AMR will be defined better as more clinical data and trials become available.

Bibliography

Raghavan, R., Jeroudi, A., Achkar, K., Gaber, A. O., Patel, S. J., & Abdellatif, A. (2010). Bortezomib in Kidney Transplantation. Journal of Transplantation, 2010, 1–6.

Authors 6
  1. Rajeev Raghavan (first)
  2. Abdallah Jeroudi (additional)
  3. Katafan Achkar (additional)
  4. A. Osama Gaber (additional)
  5. Samir J. Patel (additional)
  6. Abdul Abdellatif (additional)
References 29 Referenced 19
  1. 10.1056/NEJM199912023412303
  2. 10.1097/TP.0b013e3181d21e7f
  3. 10.1111/j.1600-6143.2009.03001.x
  4. {'key': '5', 'first-page': 'S1', 'volume': '9', 'year': '2009', 'journal-title': 'American Journal of Transplantation'} / American Journal of Transplantation (2009)
  5. 10.1097/00007890-199402270-00014 / Transplantation (1994)
  6. 10.1097/00007890-200009270-00006 / Transplantation (2000)
  7. 10.1097/MOT.0b013e3283342712
  8. 10.1034/j.1600-6143.2003.00135.x
  9. 10.1111/j.1600-6143.2009.02591.x
  10. 10.1034/j.1600-6143.2003.00121.x
  11. 10.1097/01.tp.0000231922.11453.ec
  12. 10.1111/j.1600-6143.2006.01632.x
  13. 10.1097/TP.0b013e318190af83
  14. 10.1097/TP.0b013e3181a4b91b
  15. 10.1111/j.1600-6143.2008.02461.x
  16. {'journal-title': 'Clinical transplants', 'first-page': '229', 'year': '2008', 'key': '17'} / Clinical transplants (2008)
  17. 10.1097/TP.0b013e3181d9e1c0
  18. 10.1097/TP.0b013e3181c6ff8d
  19. 10.1111/j.1600-6143.2009.02968.x
  20. 10.1056/NEJMoa0801479
  21. {'issue': '17', 'key': '22', 'first-page': '6316', 'volume': '9', 'year': '2003', 'journal-title': 'Clinical Cancer Research'} / Clinical Cancer Research (2003)
  22. 10.1038/nrneph.2009.233
  23. 10.1038/nm1763
  24. {'key': '26'}
  25. 10.1016/j.clinthera.2009.11.012
  26. 10.1038/leu.2009.83 / Leukemia (2009)
  27. 10.1056/NEJMoa030288
  28. {'key': '30', 'first-page': '171', 'volume': '10', 'year': '2010', 'journal-title': 'American Journal of Transplantation'} / American Journal of Transplantation (2010)
  29. {'journal-title': 'Clinical transplants', 'first-page': '339', 'year': '2009', 'key': '32'} / Clinical transplants (2009)
Dates
Type When
Created 14 years, 11 months ago (Sept. 27, 2010, 10:38 a.m.)
Deposited 8 years, 2 months ago (June 19, 2017, 6:31 a.m.)
Indexed 6 months, 1 week ago (Feb. 21, 2025, 11:18 a.m.)
Issued 15 years, 8 months ago (Jan. 1, 2010)
Published 15 years, 8 months ago (Jan. 1, 2010)
Published Print 15 years, 8 months ago (Jan. 1, 2010)
Funders 0

None

@article{Raghavan_2010, title={Bortezomib in Kidney Transplantation}, volume={2010}, ISSN={2090-0015}, url={http://dx.doi.org/10.1155/2010/698594}, DOI={10.1155/2010/698594}, journal={Journal of Transplantation}, publisher={Wiley}, author={Raghavan, Rajeev and Jeroudi, Abdallah and Achkar, Katafan and Gaber, A. Osama and Patel, Samir J. and Abdellatif, Abdul}, year={2010}, pages={1–6} }